$USNA

FULLER GILBERT A sold $20K of USNA

FULLER GILBERT A sold 1,057 shares of USANA HEALTH SCIENCES INC (USNA) at $18.66 on 2026-05-22.

Original reporting
SEC EDGAR · FULLER GILBERT A
Published May 26, 2026, 3:37 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 26, 2026, 3:44 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$USNA
Bearish
medium confidence
Mentioned
$USNA
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$USNABearishMed
01

Why it matters

Because the filing only documents an open-market sale by a director, it primarily affects short-term sentiment/positioning rather than providing new information about earnings, products, or guidance.

02

Market read

Traders may monitor for follow-on insider activity or unusual volume, but there is no fundamental catalyst in the text.

03

What to watch

No stated reason for the sale, no 10b5-1 plan disclosed, and the filing shows holdings after the trade are 0 shares—this can amplify optics without implying future performance.

Relevance 7/10Timing: Filing dated 2026-05-26; transaction executed 2026-05-22, so market impact is most relevant around the filing/after-hours attention window.

Background

The article is an SEC Form 4 insider transaction disclosure for USANA Health Sciences, reported via EDGAR.

Company-level read

Ticker impact

$USNABearishMedium confidence
Context

USANA director Fuller Gilbert A filed an open-market sale of 1,057 shares at $18.6648 on 2026-05-22, leaving 0 shares.

Expected impact

Near-term drift possible on attention/positioning, but likely limited magnitude because the sale is small and no 10b5-1 plan is cited.

Evidence & confidence

The article contains only an SEC Form 4 transaction (no earnings, guidance, or operational catalyst). Insider sales can be read as caution, yet the absence of a 10b5-1 plan does not, by itself, confirm negative fundamentals.

Market effects

Minimal; this is company-specific insider activity without broader sector signals.

None indicated.

None indicated.

Counterpoint

Insider selling to diversify personal exposure is common and the disclosed size/value is modest, so it may not reflect a bearish view on USNA fundamentals.

Key entities

  • USANA HEALTH SCIENCES INC

    Subject of the insider transaction disclosure; director Fuller Gilbert A sold 1,057 shares.

  • FULLER GILBERT A

    USANA director who executed the open-market sale and reported holdings after the transaction.

Related articles

$USNAHigh

USANA HEALTH SCIENCES INC (USNA): Results of Operations and Financial Condition

USANA HEALTH SCIENCES INC (USNA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026earningsreleaseex991.htm EX-99.1 Document USANA Health Sciences Reports Second Quarter 2026 Results Company Continues Evolution to a Diversified, Omnichannel Health and Wellness Business SALT LAKE CITY, August 4, 2026 (BUSINESS WIRE)—USANA Health Sciences, Inc. (N